Data

AARP, tech firms to test voice-based health tools among senior set

AARP, tech firms to test voice-based health tools among senior set

By

Pillo's voice-activated robot will be studied among those 50-plus with diabetes. The robot uses facial recognition and can respond HIPAA-compliantly to questions.

'Will Marcel replace creatives?': Sadoun faces deluge of questions from Publicis staff and clients

'Will Marcel replace creatives?': Sadoun faces deluge of questions from Publicis staff and clients

By

Just after the launch of Marcel, Publicis chief executive Arthur Sadoun was bombarded with questions from a packed room of clients, staff, and journalists.

Two drugs in the pipeline representing unique marketing challenges

Two drugs in the pipeline representing unique marketing challenges

By

Two touted products in the pipeline reflect three of medical marketing's most profound modern-era challenges.

Infographic | MSLs by the numbers

Infographic | MSLs by the numbers

Medical science liaisons are essential participants in most aspects of the commercialization process.

Ogilvy unveils new identity: CEO Seifert explains agency's new structure and purpose

Ogilvy unveils new identity: CEO Seifert explains agency's new structure and purpose

By

Ogilvy is ditching Mather, introducing a new corporate identity and cementing months of streamlining with a simplified organizational structure that chief executive John Siefert says will "build a new model for our industry".

Transparency may have taken a back seat on this diversity drive

Transparency may have taken a back seat on this diversity drive

By

MM&M/Publicis Health's first Diversity Survey reveals some notable shifts to making the healthcare industry more inclusive, yet many agencies didn't feel like opening up about their diversity numbers.

AstraZeneca reprimanded by UK drug regulator for 'misleading' press release

AstraZeneca reprimanded by UK drug regulator for 'misleading' press release

By

A UK drug regulator has ruled that a 2017 press release from AstraZeneca was "misleading" as data "had not been presented in a balanced way", following a complaint from a fellow pharma firm.

Rethinking disability targeting

Rethinking disability targeting

If we properly and intentionally use the power of targeted marketing on behalf of our disabled customers, we might drive real value for an audience we've ignored for too long.

GDPR: How to make sure your business is ready

GDPR: How to make sure your business is ready

As of May 25, Europe's groundbreaking General Data Protection Regulation (GDPR) will take effect, fundamentally changing the way businesses and government agencies deal with personal data.

4As O'Brien: How healthcare marketing has changed under Trump

4As O'Brien: How healthcare marketing has changed under Trump

By

Speakers at the Coalition for Healthcare Communication conference discussed how regulations from the White House and FDA have affected healthcare comms.

Becky Chidester,  Wunderman Health

Becky Chidester, Wunderman Health

Becky Chidester is CEO of Wunderman Health.

Former FDA commissioner Califf to pharma: opening up on health data requires overcoming risk

Former FDA commissioner Califf to pharma: opening up on health data requires overcoming risk

By

Califf spoke about the importance of more data to faster and cheaper drug development at the NewYorkBIO conference.

Health brands need to consider the human side of patients, HCPs, and stakeholders

Health brands need to consider the human side of patients, HCPs, and stakeholders

Croom Lawrence and Kent Groves of Merkle Health explain being human.

A tale of two lung cancer immunotherapies: Merck's Keytruda takes the reins

A tale of two lung cancer immunotherapies: Merck's Keytruda takes the reins

By

Opdivo's commercial potential will likely take a hit in the wake of new Keytruda data, but the impact may depend on the ability of BMS to market the message that its I-O/I-O combo allows patients to delay chemo.

David Ebersman, Lyra Health

David Ebersman, Lyra Health

David Ebersman is cofounder and CEO of Lyra Health.

Thacher Hussain, WiserCare

Thacher Hussain, WiserCare

Thacher Hussain is the front end developer (also WEGO Health advisory board member) at WiserCare.

William King, Zephyr Health

William King, Zephyr Health

William King is founder and executive chairman of Zephyr Health.

Scarlet Shore, Verily

Scarlet Shore, Verily

Scarlet Shore is product manager and platform lead, Project Baseline at Verily.

Justin Chase, Intouch Solutions

Justin Chase, Intouch Solutions

Justin Chase is EVP and head, innovation and media at Intouch Solutions.

Edie DeVine, GCI Health

Edie DeVine, GCI Health

Edie DeVine is SVP, U.S. director of medical and health technology at GCI Health.

Kevin Johnson, Marketeching

Kevin Johnson, Marketeching

Kevin Johnson is president of Marketeching.

One month out: Top 6 steps for GDPR compliance

One month out: Top 6 steps for GDPR compliance

On May 25, 2018 the European Union's General Data Protection Regulation, commonly called GDPR, will become not only the law of the land in Europe but across the globe.

ePharma: Boehringer Ingelheim and Aptus Health partner for asthma brand awareness

ePharma: Boehringer Ingelheim and Aptus Health partner for asthma brand awareness

Jim Boushie, director of respiratory marketing at Boehringer Ingelheim (BI) and David Laros, VP of analytics and commercial effectiveness at Aptus Health, came together to lead a joint ePharma session in March titled "Synchronized HCP and consumer campaigns: At the point of care and beyond."

High-profile candidates challenge marketers well in advance of launch

High-profile candidates challenge marketers well in advance of launch

By

With pharma facing ongoing scrutiny of its pricing practices, medical marketers are increasingly asked to demonstrate the superior value of new therapies. High-profile candidates in immunology, pain management, and melanoma challenge marketers well in advance of launch.

Standing out in the era of value-based healthcare marketing

Standing out in the era of value-based healthcare marketing

With healthcare evolving from a fee-for-service system toward one that bases payment on outcomes, marketers must speak to customers in value-oriented messages.

In [Insert Company Here] We Trust?

In [Insert Company Here] We Trust?

Whether it's data or marketing dollars, there should be no surprises when you partner with a company.

AI's marketing problem: Inflated claims, outsized expectations may actually be slowing AI's move into clinical practice

AI's marketing problem: Inflated claims, outsized expectations may actually be slowing AI's move into clinical practice

By

The potential is real, but companies and technology gurus often speak of machine learning as a catch-all solution. The hype may be slowing AI's incremental growth in healthcare, experts say.

Get to know your data scientist: Four data aces share their knowledge

Get to know your data scientist: Four data aces share their knowledge

By

Four data aces share their backgrounds, inspirations, and guiding philosophies

Speaker bureaus must change to stay relevant, experts say

Speaker bureaus must change to stay relevant, experts say

By

To remain relevant, speakers bureaus must evolve to a strategic marketing tactic with personalized messaging to the customer.